Dorzolamide/Timolol Labatec 20.0 mg/ml

Dorzolamide/Timolol Labatec 20.0 mg/ml is a medicine authorised by Swissmedic under authorisation number 68596. The authorisation holder is Labatec Pharma SA. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 07 July 2022 and the authorisation is limited until 06 July 2027. The export lists no ATC code for this medicine.

  • Dispensing category B
  • Authorisation number 68596
  • Synthetic medicines
Authorisation data
Authorisation number68596
NameDorzolamide/Timolol Labatec 20.0 mg/ml
Full nameDorzolamide/Timolol Labatec 20.0 mg/ml, 5.0 mg/ml, collyre en solution
Authorisation holderLabatec Pharma SA
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codenot stated
First authorisation07 July 2022
Authorisation validity06 July 2027
Strengths
No.NameDispensing categoryAuthorisation date
1Dorzolamide/Timolol Labatec 20.0 mg/ml, 5.0 mg/ml, collyre en solutionB07 July 2022

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
The Swissmedic export lists no pack sizes for this medicine.

Scroll the table sideways

Other medicines from this authorisation holder

Frequently asked questions

Is Dorzolamide/Timolol Labatec 20.0 mg/ml authorised in Switzerland?

Yes. Dorzolamide/Timolol Labatec 20.0 mg/ml is authorised by Swissmedic under authorisation number 68596, data as of 01 September 2026. The authorisation is limited until 06 July 2027.

Which dispensing category does Dorzolamide/Timolol Labatec 20.0 mg/ml have?

Dorzolamide/Timolol Labatec 20.0 mg/ml is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Dorzolamide/Timolol Labatec 20.0 mg/ml?

The authorisation holder is Labatec Pharma SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com